KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,855,400 | +115.6% | 509,810 | +74.8% | 1.62% | +127.9% |
| Q2 2023 | $4,107,178 | +52.5% | 291,703 | +16.6% | 0.71% | +21.5% |
| Q1 2023 | $2,692,765 | -6.0% | 250,257 | +30.8% | 0.59% | -23.2% |
| Q4 2022 | $2,865,779 | +76.9% | 191,307 | +51.6% | 0.76% | +65.5% |
| Q3 2022 | $1,620,000 | +34.1% | 126,192 | +1.2% | 0.46% | +3.6% |
| Q2 2022 | $1,208,000 | +2.8% | 124,708 | +5.5% | 0.44% | +29.4% |
| Q1 2022 | $1,175,000 | -12.2% | 118,247 | +4.1% | 0.34% | +16.6% |
| Q4 2021 | $1,338,000 | -10.3% | 113,644 | +41.0% | 0.30% | -14.7% |
| Q1 2021 | $1,492,000 | +12.6% | 80,603 | +7.5% | 0.35% | +2.1% |
| Q4 2020 | $1,325,000 | – | 75,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |